| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/22/2006 | EP1381620B1 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 03/22/2006 | EP1377586B1 Tricyclic diazepines as tocolytic oxytocin receptor antagonists |
| 03/22/2006 | EP1377294B1 Use of neuroactive substances for the treatment of parkinsons disease and pharmaceutical combination |
| 03/22/2006 | EP1368345B1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 03/22/2006 | EP1366052B1 Novel multi-ring organic compounds for regulating gut motility and food intake |
| 03/22/2006 | EP1338281B1 Method for producing an immunotropic antiviral preparation |
| 03/22/2006 | EP1337246B1 Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence |
| 03/22/2006 | EP1328509B1 Methods of producing oxazolidinone compounds |
| 03/22/2006 | EP1328253B1 Administration of a thiol-based chemoprotectant compound |
| 03/22/2006 | EP1322635B1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 03/22/2006 | EP1322162B1 Disinfectant agent |
| 03/22/2006 | EP1313463B1 Fatty acid analogues for the treatment of cancer |
| 03/22/2006 | EP1311522B1 New immunoeffector compounds |
| 03/22/2006 | EP1309586B1 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders |
| 03/22/2006 | EP1309324B1 Anticonvulsant derivatives useful for treating and preventing the development of type ii diabetes mellitus and syndrome x |
| 03/22/2006 | EP1301516B1 Modulators of protein tyrosine phosphatases (ptpases) |
| 03/22/2006 | EP1294353B1 Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals |
| 03/22/2006 | EP1278495A4 Topical compositions containing prostaglandin e 1? |
| 03/22/2006 | EP1274419B1 Zinc amino acid chelates having ligands comprised of glycine and a sulfur-containing amino acid |
| 03/22/2006 | EP1272488B1 Tri-aryl-substituted-ethane pde4 inhibitors |
| 03/22/2006 | EP1269845B1 Bacterial growth regulators or inhibitors with the use of 1,5-d-anhydrofructose |
| 03/22/2006 | EP1248618B1 Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- 2,3']bipyridinyl |
| 03/22/2006 | EP1244660B1 Methods and compositions for the treatment of pain |
| 03/22/2006 | EP1221847A4 Methods of enhancing chemotherapy |
| 03/22/2006 | EP1220862B1 Purine derivatives |
| 03/22/2006 | EP1212089B1 Synergistic combination of roflumilast and salmeterol |
| 03/22/2006 | EP1207867B1 Oral pharmaceutical forms of administration with a delayed action with tramadol |
| 03/22/2006 | EP1200433B1 C-6 RING-SUBSTITUTED PYRIDO[1,2-a]BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS |
| 03/22/2006 | EP1194121B1 Steroid solution aerosol products with enhanced chemical stability |
| 03/22/2006 | EP1165579B1 Method for producing endotoxin-free nucleic acids |
| 03/22/2006 | EP1140924B1 Piperazine derivatives |
| 03/22/2006 | EP1140840B1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 03/22/2006 | EP1139743B1 Exo-s-mecamylamine formulation and use in treatment |
| 03/22/2006 | EP1107963B1 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 03/22/2006 | EP1090123B1 Polyketides and their synthesis |
| 03/22/2006 | EP1051161B1 Method for treating alzheimer's disease |
| 03/22/2006 | EP1029541B1 Therapeutic or prophylactic agent for glomerulopathy |
| 03/22/2006 | EP1020426B9 Amine derivatives and process for producing the same |
| 03/22/2006 | EP1017403B1 Use of zinc hyaluronate against peptic ulcer |
| 03/22/2006 | EP1011695B1 Use of neurotoxin therapy for treatment of prostate disorders |
| 03/22/2006 | EP1005480B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 03/22/2006 | EP0962456B1 Cyclic ketone derivative and pharmaceutical use thereof |
| 03/22/2006 | EP0946155B1 Pharmaceutical composition for treating fecal incontinence and anal itch |
| 03/22/2006 | EP0915700B1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 03/22/2006 | EP0871440B1 Treatment of negative and cognitive symptoms of schizophrenia with glycine uptake antagonists |
| 03/22/2006 | EP0789564B1 Polynucleotide compositions |
| 03/22/2006 | CN1751061A Antitumoral d-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates |
| 03/22/2006 | CN1751060A Antitumoral 18a-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates |
| 03/22/2006 | CN1751059A 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action |
| 03/22/2006 | CN1751057A Bicyclic carbohydrate compounds useful in the treatment of infections caused by flaviviridae sp., such as hepatitis c and bovine viral diarrhea viruses |
| 03/22/2006 | CN1751054A Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators |
| 03/22/2006 | CN1751052A Therapeutic agents |
| 03/22/2006 | CN1751051A Cephalosporin in crystalline form |
| 03/22/2006 | CN1751050A Benzamide derivatives as oxytocin agonists and vasopressin antagonists |
| 03/22/2006 | CN1751048A Method for preparing polymorphism of irinotecan hydrochloride |
| 03/22/2006 | CN1751047A Triazole compounds useful in therapy |
| 03/22/2006 | CN1751046A Substituted hexahydropyrazino(1,2-a)pyrimidin-4,7-dion derivatives, method for the production and use thereof as medicaments |
| 03/22/2006 | CN1751044A Sulfonamide substituted xanthine derivatives for use as PEPCK inhibitors |
| 03/22/2006 | CN1751043A Imidazo[4,5-b]quinoline-derivatives and their use as no-synthase inhibitors |
| 03/22/2006 | CN1751042A Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 03/22/2006 | CN1751040A Benzofuran oxyethylamines serving as antidepressant drugs and anxiolytic drugs |
| 03/22/2006 | CN1751037A Sulfonamide derivatives as PPAR modulators |
| 03/22/2006 | CN1751036A Substituted 3-(benzoylureido)-thiophene derivatives, method for the production and use thereof |
| 03/22/2006 | CN1751033A Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof |
| 03/22/2006 | CN1751032A Polymorph of {6,7-bis(2-methoxy-ethoxy)-quinazolin-4-yl}-(3e) |
| 03/22/2006 | CN1751031A HIV replication inhibiting pyrimidines and triazines |
| 03/22/2006 | CN1751030A HIV replication inhibiting pyrimidines and triazines |
| 03/22/2006 | CN1751029A 2-aminoethyl substituted pyrimidin-2-ones, cyclopropanes, pyrazolines, pyrimidines and benzothiazepines and their use as urotensin ii and somatostatin 5 receptor ligands |
| 03/22/2006 | CN1751028A Non-nucleoside reverse transcriptase inhibitors |
| 03/22/2006 | CN1751027A Spermicidal and/or antifungal composition and methods of using the same |
| 03/22/2006 | CN1751023A Piperidine-benzenesulfonamide derivatives |
| 03/22/2006 | CN1751022A Method for production of the R,R (or S,S) configuration of glycopyrronium stereoisomers |
| 03/22/2006 | CN1751021A Crystalline forms of optical enantiomers of modafinil and method for the production |
| 03/22/2006 | CN1751019A Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
| 03/22/2006 | CN1751018A 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases |
| 03/22/2006 | CN1751010A Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them |
| 03/22/2006 | CN1750870A Fine particles, method and device for preparation thereof, and agent for parenteral injection and method for production thereof |
| 03/22/2006 | CN1750839A Administration of capsaicinoids |
| 03/22/2006 | CN1750835A Compounds for the treatment of pain |
| 03/22/2006 | CN1750834A Combination therapy for treating protein deficiencies |
| 03/22/2006 | CN1750833A Compounds for the normalization of the sleep/wake cycle |
| 03/22/2006 | CN1750832A Blood-vessel-growth promoter |
| 03/22/2006 | CN1750831A Therapeutic agent for hemorrhoidal disease |
| 03/22/2006 | CN1750830A Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin II antagonist for stroke prevention |
| 03/22/2006 | CN1750829A Formulations of glucocorticoids to treat pathologic ocular angiogenesis |
| 03/22/2006 | CN1750828A Use of steroids to treat persons suffering from ocular disorders |
| 03/22/2006 | CN1750827A Method of treating nausea, vomiting, retching or any combination thereof |
| 03/22/2006 | CN1750826A Use of R-10-hydroxy-10, 11-dihydro-carbamazepine in neuropathic pain |
| 03/22/2006 | CN1750825A Flavone acetic acid analogs and methods of use thereof |
| 03/22/2006 | CN1750824A 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-3-quinolinecarbonitriles for the treatment of ischemic injury |
| 03/22/2006 | CN1750823A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/22/2006 | CN1750822A Method of treating post operative nausea and vomiting |
| 03/22/2006 | CN1750821A Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives |
| 03/22/2006 | CN1750820A Thiazole and oxazole derivatives which modulate PPAR activity |
| 03/22/2006 | CN1750819A A method of treatment or prophylaxis of symptoms of herpes viral infection |
| 03/22/2006 | CN1750818A Injectable liquid formulation of paracetamol |
| 03/22/2006 | CN1750817A Use of the (1s, 2r) enantiomer of milnacipran for the preparation of a drug |
| 03/22/2006 | CN1750816A Composition comprising cysteamine for improving immunity of animals |
| 03/22/2006 | CN1750811A Stable composition comprising particles in a frozen aqueous matrix |
| 03/22/2006 | CN1750810A A low dose corticosteroid composition |